Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Allan

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Vaccines|February 28, 2023
COVID-19 Vaccine Status, Intent, Hesitancy, and Disease-Related Beliefs in People with Multiple SclerosisLisa Grech, Alastair Kwok, Mike Nguyen, et al.
Multiple Sclerosis and Related Disorders|October 6, 2021
Improving the detection and treatment of depression in Australians with multiple sclerosis: A qualitative analysisAssunta Hunter, Claudia H Marck, Ernest Butler, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Assessment and treatment of depression in people with multiple sclerosis: A qualitative analysis of specialist clinicians' experiencesClaudia H Marck, Assunta Hunter, Ernest Butler, et al.
Neuropsychological Rehabilitation|January 4, 2026
Depression management in multiple sclerosis (MS) -Patient and clinician perspectives and recommendationsLisa Grech, Michelle Allan, Karen-Leigh Edward, et al.
Multiple Sclerosis and Related Disorders|June 4, 2026
Utility, validity and acceptability of survey depression and anxiety screening tools for routine multiple sclerosis clinic administrationRuby Hamer, Michelle Allan, David Skvarc, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2026
Utility, validity, feasibility and acceptability of a clinician-administered depression, two-question screening tool for routine multiple sclerosis clinic administrationLisa Grech, Michelle Allan, David Skvarc, et al.
BMJ Open Sport & Exercise Medicine|February 25, 2026
Clinician-led, single-blind, randomised controlled trial evaluating the efficacy of a high-intensity resistance and impact training intervention for improving health-related quality of life in people with multiple sclerosis: protocol for STRONG-MSLisa Grech, Belinda Beck, David Scott, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Vaccines|February 28, 2023
COVID-19 Vaccine Status, Intent, Hesitancy, and Disease-Related Beliefs in People with Multiple SclerosisLisa Grech, Alastair Kwok, Mike Nguyen, et al.
Multiple Sclerosis and Related Disorders|October 6, 2021
Improving the detection and treatment of depression in Australians with multiple sclerosis: A qualitative analysisAssunta Hunter, Claudia H Marck, Ernest Butler, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Assessment and treatment of depression in people with multiple sclerosis: A qualitative analysis of specialist clinicians' experiencesClaudia H Marck, Assunta Hunter, Ernest Butler, et al.
Neuropsychological Rehabilitation|January 4, 2026
Depression management in multiple sclerosis (MS) -Patient and clinician perspectives and recommendationsLisa Grech, Michelle Allan, Karen-Leigh Edward, et al.
Multiple Sclerosis and Related Disorders|June 4, 2026
Utility, validity and acceptability of survey depression and anxiety screening tools for routine multiple sclerosis clinic administrationRuby Hamer, Michelle Allan, David Skvarc, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 26, 2026
Utility, validity, feasibility and acceptability of a clinician-administered depression, two-question screening tool for routine multiple sclerosis clinic administrationLisa Grech, Michelle Allan, David Skvarc, et al.
BMJ Open Sport & Exercise Medicine|February 25, 2026
Clinician-led, single-blind, randomised controlled trial evaluating the efficacy of a high-intensity resistance and impact training intervention for improving health-related quality of life in people with multiple sclerosis: protocol for STRONG-MSLisa Grech, Belinda Beck, David Scott, et al.
Pageof 2